We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hemogenyx Pharmaceuticals Plc | LSE:HEMO | London | Ordinary Share | GB00BYX3WZ24 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.002 | 0.13% | 1.567 | 1.536 | 1.598 | 1.55 | 1.538 | 1.55 | 4,833,427 | 16:35:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.98M | -0.0035 | -4.40 | 17.59M |
Date | Subject | Author | Discuss |
---|---|---|---|
14/10/2021 16:25 | Where is this going - worth a quick trade? - | tomboyb | |
14/10/2021 16:14 | The only reason this was still the same share price as 2-3 years ago despite the quadrupling of shares in issue was the hope/impression that HEMO would licence their lead prospect CDX to Lilly imo. The RNS of April 14th this year confirmed otherwise - Lilly declined to licence CDX and in fact HEMO were now looking to licence their own IP (plus some unspecified modifications) back from Lilly, eventualy leading to yesterday's RNS. How that was ever going to be good news I'm not sure. | on target | |
14/10/2021 16:10 | I've not been following too closely so why the fall back apart from the reason I said. Have people misread the Rns or is it a case of sheep following sheep ? | dave4545 | |
14/10/2021 16:06 | dave - more likely the mugs on the lse thread realising they should have done some research of their own (like maybe read an RNS or two) rather than just lapping up every word the usual suspects posted. | on target | |
14/10/2021 15:59 | Pure example of how this market is all pump and dumpers and day traders, nearly everybody who bought yesterday now cannot bare to hold and have their money "stuck" in one stock drifting. This is going to give a great buy oportunity for others on sidelines like me | dave4545 | |
14/10/2021 09:57 | Most stocks are forward sold insider placing a as the market makers dump stock knowing the company has contacted them for a raise. However feel down here it's a good trade back to 2.5 | kirk 6 | |
14/10/2021 08:50 | Time for a rebound. After this huge manipulated drop brought on only by fear. | luckyabbeygale | |
14/10/2021 08:45 | This Dr. Alan E. Walt's, is he an employee or yet another new Hemocasino product?The way things are going it wouldn't surprise me if MadVlad is sniffing around for another CLN.......... | badger60 | |
13/10/2021 17:00 | Davetsmummy- he is a total loon brain - AVOID. | smcl | |
13/10/2021 15:19 | Lost out on the rise since I did not sell, and at least buyers are returning. | luckyabbeygale | |
13/10/2021 13:38 | Is a placing on route | jaforsadi | |
13/10/2021 13:24 | Why dont you go and disappear badger you psycho nut job....I always thought you were a mental case... | davevtsmummy | |
13/10/2021 12:32 | Why doesn't Vlad devote time energy an resources to curing covid using Ivermectin? | badger60 | |
13/10/2021 12:01 | Looks like the 2mio loan to Orgenesis is due for repayment this month........I wonder if we'll get an RNS with the details? | badger60 | |
13/10/2021 11:46 | Today's RNS must be a bit of an embarrassment to MadVlad.....,he hasn't tweeted a word about it.When do Hemo have to repay the 2 Mio loan back to Orgenesis......this year some time, isn't it? | badger60 | |
13/10/2021 11:09 | Well played. | badger60 | |
13/10/2021 11:07 | my sell order triggered at 2.75p.. in from 1.8p That’ll do, don’t rate the longer term prospects much on the back of today’s cash bleed announcement. | phil2003 | |
13/10/2021 10:38 | JHFH Many thanks for your very kind post on the other thread. I am one of very many who have difficult issues to deal with in life, and someone taking time out to post a positive response is very uplifting, and worth its weight in gold. Definitely worth a little prayer. ;+) | badger60 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions